Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
This is a pilot sub-study of patients receiving myeloablative transplant using total body irradiation (TBI) or total marrow irradiation (TMI) in their preparative regimen. The objective of this stub-study is to estimate the heterogeneity in cellular proliferation (FLT-PET uptake) as well the heterogeneity in marrow composition distribution (measured using whole body water-fat MRI) using positron emission tomography imaging. This will be used to design future trials as well as to determine the feasibility of PET and MRI imaging.
Inclusion Criteria:
Diagnosis of hematologic malignancy and fitting into one of the following categories:
Aged 18 years and older
Not pregnant - women of childbearing potential will have a confirmatory pregnancy test prior to each imaging per routine procedures
Adequate renal function (estimated glomerular filtration rate > 60 ml/min) as determined by a serum creatinine level performed as a part of standard of care within 7 days of imaging
Able and willing to provide written consent
Exclusion Criteria:
Otherwise eligible patients meeting one or more of the contraindicates for an MRI, may enroll in the study without undergoing the MRI: